An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Children with growth failure due to inadequate secretion of growth hormone or growth
retardation due to Turner's syndrome are individually dosed and treated for 12 weeks